In this study, we performed a meta-analysis to evaluate the prognostic value of ER and its two subtypes (ER α and ER β) in patients with epithelial ovarian cancer, aiming to provide more strategies for follow-up and targeted regimens. This evidence concerns the gene ESR1 and ovarian carcinoma.